Orlando Daytona Beach Melbourne, FL, July 28, 2026 —

The Florida Department of Health has released new guidelines for healthcare providers concerning the prescription of psychotropic medications for young individuals. The updated advice targets children and teenagers between the ages of 5 and 17 who are experiencing conditions such as anxiety, depression, or Attention-Deficit/Hyperactivity Disorder (ADHD).

According to the new guidance, healthcare professionals are advised to refrain from prescribing psychotropic medications for these age groups and conditions. Instead, the department recommends prioritizing and focusing on alternative treatment modalities. These alternatives include psychotherapy, often referred to as talk therapy, and various behavioral management strategies.

This directive from the Florida Department of Health is in line with a wider, national trend of re-evaluating the role and extent of psychiatric medication use in the pediatric and adolescent populations. The shift suggests a growing emphasis on non-pharmacological approaches for mental health conditions in youth.

The specific details regarding the implementation of these guidelines, including timelines for adoption by healthcare providers and any planned support or educational resources, were not immediately available. The exact circumstances or data that prompted the issuance of these specific recommendations were also not detailed in the provided information.

The guidance from the Florida Department of Health does not specify the outcomes of any prior assessments or reviews that may have informed this decision, nor does it detail any potential consequences for providers who do not adhere to the new recommendations. Further information on the rationale behind the advisory and its intended impact is expected.



Story summarized from the original created by Ana Goñi-Lessan, News Service of Florida on www.orlandoweekly.com, see more information here.

About The Author